GABELLI FUNDS LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$9,022,000
+20881.4%
377,505
+3540.4%
0.06%
Q1 2020$43,000
-14.0%
10,3700.0%0.00%
Q4 2019$50,000
-20.6%
10,3700.0%0.00%
Q3 2019$63,000
-6.0%
10,3700.0%0.00%
Q2 2019$67,000
-9.5%
10,3700.0%0.00%
Q1 2019$74,000
+48.0%
10,3700.0%0.00%
Q4 2018$50,000
-34.2%
10,3700.0%0.00%
Q3 2018$76,000
+15.2%
10,3700.0%0.00%
Q2 2018$66,000
+17.9%
10,3700.0%0.00%
Q1 2018$56,00010,3700.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders